Compare Enveric Biosciences Inc (ENVB) vs Etsy Inc (ETSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Etsy Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Etsy Inc trades at $80.12 (market cap $7.38B). The key difference: Etsy Inc is far larger — about 1190.3× Enveric Biosciences Inc's market cap, and Etsy Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | ETSY | |
|---|---|---|
Market Cap | $6.20M | $7.38B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $86.47 |
52-Week Low | $1.27 | $44.05 |
Enterprise Value | $1.30M | $9.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.
Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.
ETSY trades at $85.55, up 4.0% over 24 hours, with a bullish technical signal and consistent earnings beats in recent quarters. The company reported Q2 2026 EPS of $0.98, exceeding expectations, and announced a $2 billion share repurchase program alongside a 12% workforce reduction to boost efficiency. Revenue growth remains stable at $2.9 billion for 2026, though net income margins have moderated from prior years.
Outlook is positive with raised 2026 guidance and AI-driven marketplace improvements, but risks include high debt levels and competitive pressures. Analysts are evenly split between Buy and Hold ratings, with a consensus price target of $85.71, suggesting limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →
